888.435.2220
info@medicure.com
MPH.V
Toggle navigation
Home
Products
Aggrastat (tirofiban HCI)
In Development
Business Development
Generic Products
Tardoxal
News
News Releases
Get News Alerts by Email
Investors
Overview
Corporate Presentation
Corporate Governance
About Us
About Medicure
Management
Board of Directors
Careers
Corporate Compliance
Contact
News Releases
News
News Releases
News Releases
Get News Alerts by Email
Get News Alerts by Email
Year
All Years
2018
2017
2016
2015
2014
2013
2012
2011
Keywords
Go
Advanced Search
Search
Search Headlines Only
From
To
Dec 2, 2015
Medicure Announces PDUFA Action Date for New Aggrastat Indication
Nov 25, 2015
Medicure Announces Grant of Stock Options
Nov 9, 2015
Medicure Reports Third Quarter 2015 Financial Results
Nov 3, 2015
Medicure Q3 Results and Conference Call Dates
Sep 10, 2015
Medicure Announces Filing of sNDA for New AGGRASTAT® Indication
Show
5
10
25
50
100
per page
«
1
2
3
4
»
